These students did their practical work period (stage) in the Research section, Dept. of Genetics, and their work led to a co-authorship (underlined) on a recent paper.
Using genome-wide pathway analysis to unravel the etiology of complex diseases.
Elbers, C.C., Eijk, K.R. van, Franke, L.H., Mulder, F.F.M., Schouw, Y.T. van der, Wijmenga, C. & Onland-Moret, N.C.
Genet Epidemiol, 2009, 33(5), 419-431.
Variants in neuropeptide Y receptor 1 and 5 are associated with nutrient-specific food intake and are under recent selection in Europeans.
Elbers, C.C., Kovel, C.G.F. de, Schouw, Y.T. van der, Meijboom, J.R., Bauer, F., Grobbee, D.E., Trynka, G., Vliet-Ostaptchouk, J.V. van, Wijmenga, C. & Onland-Moret, N.C.
PLoS ONE [E], 2009, 4(9), e7070.
Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development.
Kloosterman WP, Lagendijk AK, Ketting RF, Moulton JD, Plasterk RH.
PLoS Biol. 2007, Aug;5(8):e203. [stage in Hubrecht lab]
The SPINK gene family and celiac disease susceptibility.
Wapenaar MC, Monsuur AJ, Poell J, van 't Slot R, Meijer JW, Meijer GA, Mulder CJ, Mearin ML, Wijmenga C.
Immunogenetics. 2007, May;59(5):349-57.
Evidence in favor of the contribution of genes involved in the maintenance of the extracellular matrix of the arterial wall to the development of intracranial aneurysms.
Ruigrok, Y.M., Rinkel, G.J.E., Slot, R. van ´t, Wolfs, M., Tang, S. & Wijmenga, C.
Human Molecular Genetics, 2006, 15(22), 3361-3368.
Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes.
Franke L, van Bakel H, Fokkens L, de Jong ED, Egmont-Petersen M, Wijmenga C.
Am J Hum Genet. 2006 Jun;78(6):1011-25.
Heterogeneity at the JME 6p11-12 locus: absence of mutations in the EFHC1 gene in linked Dutch families.
Pinto, D., Louwaars, S., Westland, B.E., Volkers, L., Haan, G.-J. de, Trenite, D.G., Lindhout, D. & Koeleman, B.P.C.
Epilepsia, 2006, 47(10), 1743-1746.
Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect.
Monsuur AJ, de Bakker PI, Alizadeh BZ, Zhernakova A, Bevova MR, Strengman E, Franke L, van't Slot R, van Belzen MJ, Lavrijsen IC, Diosdado B, Daly MJ, Mulder CJ, Mearin ML, Meijer JW, Meijer GA, van Oort E, Wapenaar MC, Koeleman BP, Wijmenga C.
Nature Genetics. 2005, Dec;37(12):1341-4.
The interferon gamma gene in celiac disease: augmented expression correlates with tissue damage but no evidence for genetic susceptibility.
Wapenaar MC, van Belzen MJ, Fransen JH, Sarasqueta AF, Houwen RH, Meijer JW, Mulder CJ, Wijmenga C.
J Autoimmun. 2004 Sep;23(2):183-90.
Genome-wide screen in obese pedigrees with type 2 diabetes mellitus from a defined Dutch population.
van Tilburg JH, Sandkuijl LA, Franke L, Strengman E, Pearson PL, van Haeften TW, Wijmenga C.
Eur J Clin Invest. 2003 Dec;33(12):1070-4.